Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study. - Moreno-Pérez Ó; Tejera-Muñoz A; Leiva-Mora N; Santacruz E; Sánchez-Ortiga R; Arrarte V; Climent-Grana E; Sandin M; Riera G; Lopez-Mondejar P; López-Muñoz B; Navarro C; et al. (Cardiovascular diabetology, 2026)